Healthcare provider profile · identity verified

Andrew Logan Wright, M.D.

Family Practice · CHANDLER, AZ · NPI 1669572715

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	545	169
Amlodipine Besylate	Amlodipine Besylate	313	104
Lisinopril	Lisinopril	313	95
Rosuvastatin Calcium	Rosuvastatin Calcium	290	99
Levothyroxine Sodium	Levothyroxine Sodium	253	73
Albuterol Sulfate Hfa	Albuterol Sulfate	218	88
Metformin Hcl	Metformin Hcl	167	49
Pantoprazole Sodium	Pantoprazole Sodium	156	57
Losartan Potassium	Losartan Potassium	147	46
Gabapentin	Gabapentin	127	43
Famotidine	Famotidine	120	48
Metoprolol Succinate	Metoprolol Succinate	120	37
Valsartan	Valsartan	117	38
Trazodone Hcl	Trazodone Hcl	115	42
Metformin Hcl Er	Metformin Hcl	113	36
Metoprolol Tartrate	Metoprolol Tartrate	106	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	30
Montelukast Sodium	Montelukast Sodium	101	40
Tamsulosin Hcl	Tamsulosin Hcl	99	40
Celecoxib	Celecoxib	83	41
Pioglitazone Hcl	Pioglitazone Hcl	82	24
Potassium Chloride	Potassium Chloride	81	27
Nifedipine Er	Nifedipine	78	29
Clopidogrel	Clopidogrel Bisulfate	75	27
Duloxetine Hcl	Duloxetine Hcl	74	26
Azithromycin	Azithromycin	72	65
Omeprazole	Omeprazole	71	23
Fluticasone Propionate	Fluticasone Propionate	70	34
Furosemide	Furosemide	62	23
Ozempic	Semaglutide	60	11
Clonazepam	Clonazepam	57	11
Finasteride	Finasteride	57	17
Allopurinol	Allopurinol	56	21
Carvedilol	Carvedilol	54	22
Eliquis	Apixaban	53	22
Ezetimibe	Ezetimibe	53	21
Glimepiride	Glimepiride	52	17
Pregabalin	Pregabalin	52	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	38
Hydrochlorothiazide	Hydrochlorothiazide	50	16
Tramadol Hcl	Tramadol Hcl	48	23
Buspirone Hcl	Buspirone Hcl	47	20
Hydralazine Hcl	Hydralazine Hcl	47	16
Ipratropium Bromide	Ipratropium Bromide	47	19
Atenolol	Atenolol	46	13
Baclofen	Baclofen	45	16
Methylprednisolone	Methylprednisolone	45	42
Olmesartan Medoxomil	Olmesartan Medoxomil	43	13
Jardiance	Empagliflozin	41	15
Zolpidem Tartrate	Zolpidem Tartrate	41	11
Alendronate Sodium	Alendronate Sodium	40	16
Sertraline Hcl	Sertraline Hcl	40	13
Simvastatin	Simvastatin	40	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	32
Pravastatin Sodium	Pravastatin Sodium	38	15
Trulicity	Dulaglutide	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	12
Alprazolam	Alprazolam	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	31	26
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Ondansetron Odt	Ondansetron	29	13
Esomeprazole Magnesium	Esomeprazole Magnesium	27	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	13
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Diazepam	Diazepam	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	11
Warfarin Sodium	Warfarin Sodium	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Sucralfate	Sucralfate	24	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Lactulose	Lactulose	22	suppressed
Spironolactone	Spironolactone	22	11
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Meloxicam	Meloxicam	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Ibandronate Sodium	Ibandronate Sodium	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Prolia	Denosumab	18	11
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Ramipril	Ramipril	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error